 Home > Medical News > Latest Medical News > 2022 pharmaceutical company report card: 1 company has disclosed a bright performance report, and more than 10 companies have increased their performance

2022 pharmaceutical company report card: 1 company has disclosed a bright performance report, and more than 10 companies have increased their performance

 Last Update: 2023-02-01
 Source: Internet
 Author: User

Tags

chevron annual report

pharmaceutical compounding

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently is the stage
for listed companies to disclose their 2022 performance reports and performance forecasts.
In the pharmaceutical industry, the performance of pharmaceutical companies in 2022 is also accelerating
.
According to the statistics of the data center of Oriental Fortune Network, as of January 11, about 20 pharmaceutical companies in the pharmaceutical industry have released 2022 performance reports and performance forecasts, of which 1 has disclosed bright performance reports, and more than 10 have increased their performance
.

Pharmaceutical industry (Image source: Pharmaceutical Network)

1 pharmaceutical company has disclosed its annual performance report

East Asia Pharmaceutical released its 2022 performance report on the evening of January 10, and the pharmaceutical company is also the first pharmaceutical company
to release the annual performance express.
The company expects to achieve operating income of 1.
180 billion yuan in 2022, a year-on-year increase of 65.
62%; The net profit attributable to the parent was 104 million yuan, a year-on-year increase of 51.
58%.

As for the reasons for the increase in performance, East Asia Pharmaceutical said that the main reason was that the company's new workshop of cefzoxime sodium intermediate was put into use in September 2021, and the production and sales of cefzoxime sodium intermediate in 2022 increased significantly compared with the same period of the previous year, driving the growth
of the annual performance.

According to the data, East Asia Pharmaceutical is mainly engaged in the research and development, production and sales of chemical APIs and pharmaceutical intermediates
.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.